The authors wish to make the following corrections to this paper [1]:
After the publication of this work, we were notified of the mistakes in Figure 2E and Section 3.2, which have now been updated in this correction.
Figure 2.
(E) Flow-cytometry data (upper) and graphical representation (lower) showing the effect of Garcinol, alone or in presence of Z-VAD-FMK, on U87MG or GBM8401 cells co-stained with PE-conjugated Annexin V and 7-AAD, compared with untreated control or Z-VAD-FMK-treated negative control groups. Annexin V-stained Q4 cells are early apoptotic cells, whereas Q2 cells are late apoptotic (necrotic) cells. Apoptosis (%), sum of Q4 + Q2; CTL, vehicle-treated; Neg CTL, pan-caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (Z-VAD-FMK).
and should be replaced with the following:
Figure 2.
(E) Flow-cytometry data (upper) and graphical representation (lower) showing the effect of garcinol, alone or in presence of Z-VAD-FMK, on U87MG or GBM8401 cells co-stained with PE-conjugated annexin V and 7-AAD, compared with untreated control or Z-VAD-FMK-treated negative control groups. Annexin V-stained Q3 cells are early apoptotic cells, whereas Q2 cells are late apoptotic (necrotic) cells. Apoptosis (%), sum of Q3 + Q2; CTL, vehicle-treated; Neg CTL, pan-caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (Z-VAD-FMK).
In addition, the authors reported errors in Section 3.2 when analyzing the original data in Figure 2E. Thus, the authors wish to replace the following sentence in Section 3.2:
“…and 7.97% or 14.11% apoptosis of the U87MG cells (Figure 2E), indicating that the garcinol-induced cell death was apoptotic and caspase-dependent.”
with:
“…and 7.97% or 12.99% apoptosis of the U87MG cells (Figure 2E), indicating that the garcinol-induced cell death was apoptotic and caspase-dependent.”
The corrections made in this erratum do not affect the original conclusions. The authors would like to apologize for any inconvenience caused to the readers by these changes.
References
- Liu, H.-W.; Lee, P.M.; Bamodu, O.A.; Su, Y.-K.; Fong, I.-H.; Yeh, C.-T.; Chien, M.-H.; Kan, I.-H.; Lin, C.-M. Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in STAT3/5A-Addicted Glioblastoma. Cancers 2019, 11, 1888. [Google Scholar] [CrossRef] [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).